Join us for a seminar hosted by OligoNova and SciLifeLab Drug Discovery and Development on April 9, 2024, from 13:00 - 15:00. Discover how to protect your ideas about therapeutic oligonucleotides.
Understanding intellectual property (IP) is crucial for business success. This seminar will focus on oligonucleotide inventions. Louise Tottie, Fiona Hey, and Kevin Rich will explain what you can patent, the challenges with oligonucleotides, and how to create an IP strategy to reach your business goals.
AGENDA
- Introduction
- OligoNova/SciLifeLab Drug Discovery and Development
- AstraZeneca: Peter Storm
- Ribocure: TBC
- Patentability and Strategies for Novel Therapeutic Oligonucleotides
- Potter Clarkson: Louise Tottie, Fiona Hey, and Kevin Rich
- Panel discussion questions
- Moderator: OligoNova/SciLifeLab Drug Discovery and Development
Register for the event here.
